Every open market buy and sale of Olema Oncology, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $24.7M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when OLMA insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an OLMA officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every OLMA insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Cyrus HarmonDirector | Sale | 25,000 | $11.65 | $291K | 702,770 | Jul 27Form 4 |
| Mar 4, 2026 | Shawnte MitchellChief Legal Officer | Sale | 40,000 | $23.79 | $952K | 0 | Mar 5Form 4 |
| Jan 20, 2026 | Cyrus HarmonDirector | Sale | 10,000 | $26.88 | $269K | 727,770 | Jan 21Form 4 |
| Jan 15, 2026 | Shane William Charles KovacsCh. Operating & Financial Off. | Sale | 103,822 | $28.70 | $3M | 139,727 | Jan 15Form 4 |
| Jan 14, 2026 | Cyrus HarmonDirector | Sale | 3,489 | $29.12 | $102K | 737,770 | Jan 16Form 4 |
| Jan 14, 2026 | David C. MylesCh. Discov. & Non-clin Dev Off | Sale | 110,000 | $28.25 | $3.1M | 542,761 | Jan 14Form 4 |
| Dec 23, 2025 | Naseem ZojwallaChief Medical Officer | Sale | 269,509 | $27.94 | $7.5M | 4,488 | Dec 23Form 4 |
| Dec 22, 2025 | Cyrus HarmonDirector | Sale | 2,881 | $28.53 | $82K | 741,259 | Dec 29Form 4 |
| Dec 19, 2025 | Ian T ClarkDirector | Sale | 264,800 | $29.73 | $7.9M | 0 | Dec 23Form 4 |
| Dec 19, 2025 | David C. MylesCh. Discov. & Non-clin Dev Off | Sale | 51,000 | $30.46 | $1.6M | 551,881 | Dec 23Form 4 |
| Sep 18, 2025 | Cyrus HarmonDirector | Sale | 25,000 | $8.19 | $205K | 117,028 | Sep 18Form 4 |
| Jan 8, 2025 | Bain Capital Life Sciences Investors, LLC10% owner | Buy | 300,000 | $5.76 | $1.7M | 7,800,000 | Jan 13Form 4 |
| Dec 17, 2024 | G. Walmsley GrahamDirector | Sale | 700,761 | $6.75 | $4.7M | 0 | Dec 17Form 4 |
| Dec 11, 2024 | Sean BohenPresident And CEO | Sale | 109,502 | $9.01 | $986K | 241,662 | Dec 11Form 4 |
| Dec 11, 2024 | Shane William Charles KovacsCh. Operating & Financial Off. | Sale | 35,159 | $9.01 | $317K | 543,549 | Dec 11Form 4 |
OLMA insider trading FAQ
Are OLMA insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of OLMA on the open market in 0 trades, and 6 sold $24.7M in 10 trades.
When did an OLMA insider last buy shares?
Bain Capital Life Sciences Investors, LLC (10% owner) bought 300,000 shares for $1.7M on Jan 8, 2025, reported on Jan 13, 2025.
When did an OLMA insider last sell shares?
Cyrus Harmon (Director) sold 25,000 shares for $291K on Jul 24, 2026.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
